Dynorphin A1–8
Dynorphin A1–8[edit | edit source]
Dynorphin A1–8 is a peptide fragment derived from the larger endogenous opioid peptide, dynorphin. It is part of the endorphin family and plays a significant role in modulating pain and emotion in the central nervous system.
Structure[edit | edit source]
Dynorphin A1–8 is composed of the first eight amino acids of the full dynorphin A peptide. Its sequence is:
- Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile
This sequence is crucial for its interaction with opioid receptors, particularly the kappa-opioid receptors (KORs).
Function[edit | edit source]
Dynorphin A1–8 primarily acts as an agonist at kappa-opioid receptors. These receptors are distributed throughout the brain and spinal cord and are involved in regulating pain perception, stress response, and emotional states. Activation of KORs by dynorphin A1–8 can lead to:
- Analgesia: Dynorphin A1–8 contributes to the body's natural pain-relief mechanisms.
- Dysphoria: Unlike other opioids that often produce euphoria, activation of KORs by dynorphin A1–8 can result in feelings of unease or dysphoria.
- Stress response: It plays a role in the body's response to stress, potentially influencing mood and behavior.
Clinical Significance[edit | edit source]
Research into dynorphin A1–8 and its effects on the kappa-opioid receptor system has implications for understanding and treating various conditions, including:
- Chronic pain: As a modulator of pain, dynorphin A1–8 and its analogs are studied for potential therapeutic applications in pain management.
- Depression and anxiety: Due to its role in mood regulation, targeting the dynorphin/KOR system may offer new avenues for treating mood disorders.
- Addiction: The dysphoric effects of dynorphin A1–8 may counteract the rewarding effects of drugs of abuse, suggesting a potential role in addiction treatment.
Research[edit | edit source]
Ongoing research is exploring the precise mechanisms by which dynorphin A1–8 and related peptides influence the kappa-opioid receptor system. Studies are also investigating synthetic analogs that might selectively target KORs with fewer side effects than traditional opioids.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
